CDCA7L and medulloblastoma: Huang et al. [158] reported that JPO2, a LEDGF/p75-IBD interacting partner, acts cooperatively with the c-MYC oncoprotein to potentiate its transforming activity in mammalian cells, including medulloblastoma cells.